PTK2B and central nervous system cancer: Notably, treatment of glioma cells with medium, conditioned from microglia (MCM), led to increased phosphorylation of Pyk2 at Tyr 579/580 and significantly enhanced invasiveness, even in cell lines typically characterized by low invasive potential, such as HS683.